A study to investigate the safety and concentration in the blood and urine of different dose strengths of OCT461201 in healthy volunteers

INTERVENTION: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. CONDITION: Healthy volunteers ; Not Applicable PRIMARY OUTCOME: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. SECONDARY OUTCOME: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. INCLUSION CRITERIA: The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.